Avanos Medical Statistics

Total Valuation

Avanos Medical has a market cap or net worth of $572.04 million. The enterprise value is $615.94 million.

Market Cap	572.04M
Enterprise Value	615.94M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025, before market open.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Avanos Medical has 46.24 million shares outstanding. The number of shares has decreased by -1.13% in one year.

Current Share Class	46.24M
Shares Outstanding	46.24M
Shares Change (YoY)	-1.13%
Shares Change (QoQ)	+1.74%
Owned by Insiders (%)	1.81%
Owned by Institutions (%)	95.45%
Float	45.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	14.38
PS Ratio	0.83
Forward PS	1.08
PB Ratio	0.68
P/TBV Ratio	2.07
P/FCF Ratio	5.02
P/OCF Ratio	4.26
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.57, with an EV/FCF ratio of 5.40.

EV / Earnings	n/a
EV / Sales	0.89
EV / EBITDA	6.57
EV / EBIT	12.29
EV / FCF	5.40

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.17.

Current Ratio	2.57
Quick Ratio	1.47
Debt / Equity	0.17
Debt / EBITDA	1.31
Debt / FCF	1.24
Interest Coverage	4.47

Financial Efficiency

Return on equity (ROE) is -36.78% and return on invested capital (ROIC) is 2.58%.

Return on Equity (ROE)	-36.78%
Return on Assets (ROA)	2.26%
Return on Invested Capital (ROIC)	2.58%
Return on Capital Employed (ROCE)	5.16%
Revenue Per Employee	$309,475
Profits Per Employee	-$172,699
Employee Count	2,227
Asset Turnover	0.50
Inventory Turnover	2.06

Taxes

Income Tax	-14.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.24% in the last 52 weeks. The beta is 1.14, so Avanos Medical's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-37.24%
50-Day Moving Average	12.63
200-Day Moving Average	17.24
Relative Strength Index (RSI)	46.52
Average Volume (20 Days)	401,535

Short Selling Information

The latest short interest is 1.56 million, so 3.38% of the outstanding shares have been sold short.

Short Interest	1.56M
Short Previous Month	1.13M
Short % of Shares Out	3.38%
Short % of Float	3.44%
Short Ratio (days to cover)	3.16

Income Statement

In the last 12 months, Avanos Medical had revenue of $689.20 million and -$384.60 million in losses. Loss per share was -$8.37.

Revenue	689.20M
Gross Profit	376.30M
Operating Income	50.10M
Pretax Income	14.70M
Net Income	-384.60M
EBITDA	93.80M
EBIT	50.10M
Loss Per Share	-$8.37

Full Income Statement

Balance Sheet

The company has $97.00 million in cash and $140.90 million in debt, giving a net cash position of -$43.90 million or -$0.95 per share.

Cash & Cash Equivalents	97.00M
Total Debt	140.90M
Net Cash	-43.90M
Net Cash Per Share	-$0.95
Equity (Book Value)	839.40M
Book Value Per Share	18.15
Working Capital	215.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $134.40 million and capital expenditures -$20.40 million, giving a free cash flow of $114.00 million.

Operating Cash Flow	134.40M
Capital Expenditures	-20.40M
Free Cash Flow	114.00M
FCF Per Share	$2.47

Full Cash Flow Statement

Margins

Gross margin is 54.60%, with operating and profit margins of 7.27% and -55.80%.

Gross Margin	54.60%
Operating Margin	7.27%
Pretax Margin	-57.33%
Profit Margin	-55.80%
EBITDA Margin	13.61%
EBIT Margin	7.27%
FCF Margin	16.54%

Dividends & Yields

Avanos Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.13%
Shareholder Yield	1.13%
Earnings Yield	-67.23%
FCF Yield	19.93%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Avanos Medical has an Altman Z-Score of 2.01 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.01
Piotroski F-Score	6